Lunai Bioworks Inc (LNAI)

$1.29 +0.06 (4.88%)
Market Cap 22.20M
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 269,800
Avg Vol 241,343
Day's Range N/A - N/A
Shares Out 17.21M
Stochastic %K 24%
Beta 0.39
Analysts Strong Buy
Price Target N/A

Company Profile

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform...

Phone: 305 918 1980
Address:
2080 Century Park East, Suite 906, Los Angeles, United States
Vikingsstrade
Vikingsstrade Oct. 3 at 5:29 PM
$POAI $LNAI $ORKT $LESL Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.
0 · Reply
1dk2la
1dk2la Oct. 3 at 4:19 PM
$LNAI still no trading whats going on here ?
1 · Reply
MoonCowBoy
MoonCowBoy Oct. 2 at 11:44 PM
$POAI $LNAI $ORKT $LESL .
0 · Reply
mogluk
mogluk Oct. 2 at 7:55 PM
$LNAI when will the trade resume?
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:15 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $RAYA $POAI $LNAI $ORKT .
0 · Reply
Nottrue
Nottrue Oct. 2 at 12:18 PM
$LNAI indeed european banks have not allowed trades yet or do not know how to acomodate lnai so that is lagging...wait till Euro investors come in
0 · Reply
fairytaleresearch
fairytaleresearch Oct. 2 at 7:00 AM
- $PASW ticker change from $MJID yesterday: Totally oversold - Setup for reversal - $TTNP merger today and change to $BTTC - Tiny float - $PRHI ticker change from $CNFR day before yesterday, known for spikes. Basically no volume since change - $LNAI ticker changed from $RENB
0 · Reply
Stengaard1
Stengaard1 Oct. 1 at 10:40 PM
$LNAI more than decent turnover considering most of the interested parties are still prohibited from trading (incompetent banks) - I would have thought that price would have dropped considering the appalling lack of news after the reverse split , and the absence of danish investors - but this stock never stops amazing me...
0 · Reply
Nottrue
Nottrue Oct. 1 at 9:19 PM
$LNAI
0 · Reply
Opposite_George_banned
Opposite_George_banned Oct. 1 at 6:51 PM
$LNAI it can change name as many times as it want but price action never change
0 · Reply
Latest News on LNAI
Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense

Sep 30, 2025, 9:15 AM EDT - 4 days ago

Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense

Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships

Sep 25, 2025, 8:30 AM EDT - 9 days ago

Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

Sep 24, 2025, 4:50 PM EDT - 10 days ago

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

Sep 11, 2025, 7:00 AM EDT - 23 days ago

Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

Top 3 Health Care Stocks You'll Regret Missing In Q3

Sep 9, 2025, 9:12 AM EDT - 25 days ago

Top 3 Health Care Stocks You'll Regret Missing In Q3

CERO SMMT

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

Sep 9, 2025, 8:47 AM EDT - 25 days ago

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

Lunai Bioworks Strengthens European Strategy Through Restructuring

Sep 8, 2025, 8:50 AM EDT - 26 days ago

Lunai Bioworks Strengthens European Strategy Through Restructuring

Lunai Bioworks Inc. Retains American Defense International

Sep 4, 2025, 10:05 AM EDT - 4 weeks ago

Lunai Bioworks Inc. Retains American Defense International

Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics

Aug 27, 2025, 9:45 AM EDT - 5 weeks ago

Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics

Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks

Aug 8, 2025, 10:45 AM EDT - 2 months ago

Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks

Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

Jul 28, 2025, 10:38 AM EDT - 2 months ago

Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy

Jul 17, 2025, 9:15 AM EDT - 2 months ago

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives

Jul 9, 2025, 8:00 AM EDT - 3 months ago

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

Jun 30, 2025, 9:21 AM EDT - 3 months ago

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

Jun 3, 2025, 9:15 AM EDT - 4 months ago

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 22, 2025, 3:12 PM EDT - 4 months ago

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 22, 2025, 11:05 AM EDT - 4 months ago

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

May 14, 2025, 9:15 AM EDT - 5 months ago

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics

May 13, 2025, 9:15 AM EDT - 5 months ago

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

Apr 22, 2025, 9:20 AM EDT - 5 months ago

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

Apr 9, 2025, 9:25 AM EDT - 6 months ago

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

Apr 4, 2025, 9:40 AM EDT - 6 months ago

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

Mar 3, 2025, 9:15 AM EST - 7 months ago

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Feb 26, 2025, 1:25 PM EST - 7 months ago

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Renovaro Announces $15 million in Equity Committed

Feb 26, 2025, 9:15 AM EST - 7 months ago

Renovaro Announces $15 million in Equity Committed

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

Jan 7, 2025, 6:51 PM EST - 9 months ago

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

POAI

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Jan 7, 2025, 9:15 AM EST - 9 months ago

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Renovaro Issues Shareholder Letter and Provides Corporate Update

Jan 7, 2025, 9:15 AM EST - 9 months ago

Renovaro Issues Shareholder Letter and Provides Corporate Update

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Jan 6, 2025, 9:15 AM EST - 9 months ago

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Dec 30, 2024, 9:00 AM EST - 9 months ago

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

Dec 23, 2024, 9:00 AM EST - 10 months ago

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

Renovaro Regains Compliance with NASDAQ Listing Requirement

Dec 20, 2024, 3:40 PM EST - 10 months ago

Renovaro Regains Compliance with NASDAQ Listing Requirement

Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection

Dec 20, 2024, 9:00 AM EST - 10 months ago

Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

Oct 17, 2024, 9:15 AM EDT - 1 year ago

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

Renovaro Announces Strategic Restructuring and Leadership Transition

Oct 16, 2024, 9:28 AM EDT - 1 year ago

Renovaro Announces Strategic Restructuring and Leadership Transition

RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress

Sep 13, 2024, 9:00 AM EDT - 1 year ago

RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress

RenovaroCube Announces Strategic Offering of Up to 20% Ownership

Sep 11, 2024, 9:15 AM EDT - 1 year ago

RenovaroCube Announces Strategic Offering of Up to 20% Ownership

Renovaro, Inc. Announces $10 million in Equity Committed

Jun 14, 2024, 9:06 AM EDT - 1 year ago

Renovaro, Inc. Announces $10 million in Equity Committed

Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy

May 24, 2024, 9:20 AM EDT - 1 year ago

Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB)

May 21, 2024, 8:39 AM EDT - 1 year ago

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB)

BAX RAPT SAGE TMCI

Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

Apr 30, 2024, 11:00 AM EDT - 1 year ago

Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

Apr 24, 2024, 9:00 AM EDT - 1 year ago

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient C

Apr 18, 2024, 8:45 AM EDT - 1 year ago

Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient C

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

Feb 15, 2024, 9:25 AM EST - 1 year ago

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

Statement of Renovaro Inc

Feb 14, 2024, 10:01 AM EST - 1 year ago

Statement of Renovaro Inc

AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine

Feb 13, 2024, 9:31 AM EST - 1 year ago

AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine

Renovaro Biosciences Announces Results of Special Meeting of Shareholders

Jan 25, 2024, 12:45 PM EST - 1 year ago

Renovaro Biosciences Announces Results of Special Meeting of Shareholders

Message from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MD

Jan 16, 2024, 8:00 AM EST - 1 year ago

Message from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MD

RENOVARO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Renovaro Biosciences Inc. - RENB

Jan 10, 2024, 5:21 PM EST - 1 year ago

RENOVARO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Renovaro Biosciences Inc. - RENB

Vikingsstrade
Vikingsstrade Oct. 3 at 5:29 PM
$POAI $LNAI $ORKT $LESL Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.
0 · Reply
1dk2la
1dk2la Oct. 3 at 4:19 PM
$LNAI still no trading whats going on here ?
1 · Reply
MoonCowBoy
MoonCowBoy Oct. 2 at 11:44 PM
$POAI $LNAI $ORKT $LESL .
0 · Reply
mogluk
mogluk Oct. 2 at 7:55 PM
$LNAI when will the trade resume?
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:15 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $RAYA $POAI $LNAI $ORKT .
0 · Reply
Nottrue
Nottrue Oct. 2 at 12:18 PM
$LNAI indeed european banks have not allowed trades yet or do not know how to acomodate lnai so that is lagging...wait till Euro investors come in
0 · Reply
fairytaleresearch
fairytaleresearch Oct. 2 at 7:00 AM
- $PASW ticker change from $MJID yesterday: Totally oversold - Setup for reversal - $TTNP merger today and change to $BTTC - Tiny float - $PRHI ticker change from $CNFR day before yesterday, known for spikes. Basically no volume since change - $LNAI ticker changed from $RENB
0 · Reply
Stengaard1
Stengaard1 Oct. 1 at 10:40 PM
$LNAI more than decent turnover considering most of the interested parties are still prohibited from trading (incompetent banks) - I would have thought that price would have dropped considering the appalling lack of news after the reverse split , and the absence of danish investors - but this stock never stops amazing me...
0 · Reply
Nottrue
Nottrue Oct. 1 at 9:19 PM
$LNAI
0 · Reply
Opposite_George_banned
Opposite_George_banned Oct. 1 at 6:51 PM
$LNAI it can change name as many times as it want but price action never change
0 · Reply
MarketForecasting
MarketForecasting Oct. 1 at 6:46 PM
$LNAI Company has hit the ultimate trifecta:Divorce, Bankruptcy, Name Change Divorce : Business units have been separated Bankruptcy: GediCube went under Name Change : Renevaro to Lunai
0 · Reply
Stengaard1
Stengaard1 Oct. 1 at 5:19 PM
$LNAI lunai on X https://x.com/lunaibioworks?s=21&t=ON0vo7TBVw5RLx2wUMQwWQ
0 · Reply
MarketForecasting
MarketForecasting Oct. 1 at 3:05 PM
$LNAI jack of all trades , master of none
1 · Reply
mogluk
mogluk Oct. 1 at 2:18 PM
$LNAI no trading today?
1 · Reply
Stengaard1
Stengaard1 Oct. 1 at 1:53 PM
$LNAI platform is very versatile : Parkinson & Alzheimer’s https://www.einpresswire.com/article/854022507/moleculera-biosciences-advances-first-of-its-kind-biomarker-panel-for-alzheimer-s-through-alliance-with-lunai-bioworks
1 · Reply
Luca3211
Luca3211 Oct. 1 at 1:48 PM
$LNAI
0 · Reply
SameOldMan
SameOldMan Oct. 1 at 1:33 PM
$LNAI No one has moved over, yet.
1 · Reply
beppels
beppels Oct. 1 at 6:59 AM
$CNFR BEPPELS WL 01.10.: - $PRHI, 1.22 $, 3.8 mln float, unfound ticker change from $CNFR, had some crazy spikes lately! ✅ - $MLTX, 7.2 $, 29 mln float, lost nearly 90 % in 2 days, bottom found at 6, lot of buy ratings came out yesterday with pt s up to 20 $! ✅ - $LNAI, 1.45 $, 15 mln float, changed ticker from $LNAI in ah, total novum! ✅ 👀 🔥 👀
2 · Reply
Newsfilter
Newsfilter Sep. 15 at 10:46 PM
$LNAI Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Enochian To Contact Him Directly To Discuss Their Options https://newsfilter.io/a/dad026fb05dcd66375572e60851ce0c9
0 · Reply
fla
fla Sep. 15 at 9:48 PM
$LNAI [15s. delayed]: Issued Press Release on September 15, 17:46:00: Enochian Biosciences, Inc. Investors: Last Days to Actively Particip https://s.flashalert.me/1Obuee
0 · Reply
ChartMill
ChartMill Aug. 23 at 10:05 AM
$LNAI: $LNAI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 26, 2022 in the Class Acti ... https://www.chartmill.com/stock/quote/ENOB/news?utm_source=stocktwits&utm_medium=pressRelease&utm_content=ENOB&utm_campaign=social_tracking
0 · Reply
fla
fla Aug. 23 at 9:53 AM
$LNAI [15s. delayed]: Issued Press Release on August 23, 05:45:00: ENOB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of S https://s.flashalert.me/IU2OD
0 · Reply